Med. Pro Praxi 2010; 7(6-7): 293-295

Proximal diabetic neuropathy

MUDr. Bořek Tuček,, MUDr. Radim Mazanec, Ph.D.
Neurologická klinika FN Motol, Praha

Diabetes mellitus (DM) is the most common aetiologic factor of neuropathy in the developed countries. Diabetic neuropathy (DN)

is among significant metabolic and microvascular complications of both type I and type II diabetes mellitus. Proximal diabetic amyotrophy

is a specific entity of diabetic neuropathy occurring more often in type I diabetes than type II diabetes and is not related to the

duration of DM. The incidence rate is low (0.3–1.1 %) but its course is typically dramatic with marked disability of the patient. This type

of neuropathy is reversible but improvement may be very slow and take months to occur. In a 63-year-old female patient, proximal diabetic

amyotrophy was the first sign of previously undiagnosed DM. The involvement progressed rapidly, resulting in loss of locomotor

ability within ten days, and the subsequent recovery lasted more than one year.

Keywords: diabetes mellitus, diabetic neuropathy, proximal diabetic amyotrophy, intravenous immunoglobulins

Published: September 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tuček B, Mazanec R. Proximal diabetic neuropathy. Med. praxi. 2010;7(6-7):293-295.
Download citation

References

  1. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60(1): 108-111. Go to original source... Go to PubMed...
  2. Záhumenský E, Záhumenská M. Racionální terapie diabetické polyneuropatie, Interní medicína pro praxi 2000; 5: 37-40.
  3. Moravcová E, Bednařík J. Diabetická neuropatie, Neurol. pro praxi, 2006; 2: 99-103.
  4. Bakker SJL, Heine RJ, Gans ROB. Thiamine may indirectly act as an antioxidant. Diabetologia, 1997; 40: 741-742.
  5. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med, 1999; 107(2B): 17S-26S. Go to original source... Go to PubMed...
  6. Kučera P, Kurča E. Bolestivé formy diabetickej neuropatie. In: Krahulec B, Kučera P, Kurča E, et al. Diabetická polyneuropatia II. Bratislava: ARIMES 2003: 18-35.
  7. Vondrová H. Neurologické projevy endokrinních onemocnění. Praha: GEUM 2003.
  8. Diabetes Control and Complications Trial Research Group: The effect of intensive Treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329(14): 977-986. Go to original source... Go to PubMed...
  9. Anděl M, et al. Diabetes mellitus a další poruchy metabolismu. Praha: Galén, 2001: 208 s.
  10. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Čes a slov Neurol Neurochir, 2002; 65/98: 135-138.
  11. Ziegler D, et al. Léčení symptomatické diab. periferní neuropatie antioxidantem kyselinou alfa-lipoovou, Diabetologia 1995; 38: 1425-1433. Go to original source... Go to PubMed...
  12. Vinik AI, Pittenger GL, Barlow P, Mehrabyan A. Diabetic Neuropathies. In: LeRoith D, Taylor SI, Olefsky JM. Diabetes Mellitus. 3rd edition. Lippincott Williams Wilkins, 2004: 1331-1364.
  13. Grofik M, Nosáľ V, Kurča E, Kučera P. Neurologické prejavy diabetes mellitus. Neurol. pro praxi, 2005; 1: 25-30.
  14. Dyck PJB, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology, 1999; 53: 2113-2121. Go to original source... Go to PubMed...
  15. Ambler Z. Bolestivé diabetické neuropatie. Bolest 2008; 1: 9-13.
  16. Vondrová H. Léčba diabetické polyneuropatie. Neurol. pro praxi, 2008; 9(4): 245-251.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.